INTRODUCTION:

Herbal drug technology is a branch of pharmaceutical science that focuses on transforming traditional herbal medicines into scientifically validated, standardized, and quality-controlled therapeutic products¹. For centuries, traditional systems of medicine such as Ayurveda, Unani, Siddha, and Traditional Chinese Medicine have historically relied on herbal remedies as a core component of treatment. However, inadequate standardization, quality assurance, and scientific validation has often limited their acceptance in modern healthcare systems². To overcome these challenges, herbal drug technology integrates modern analytical tools, extraction techniques, formulation science, and biotechnological advancements to improve the safety, effectiveness, and uniformity of herbal formulations³.

The process involves several crucial steps such as authentication of raw materials, phytochemical screening, isolation and characterization of active constituents, and development of novel dosage forms. Advanced analytical techniques like HPTLC, HPLC, GC–MS, and spectroscopic methods ensure precise identification and quantification of phytoconstituents, minimizing adulteration and variability⁴. Furthermore, the incorporation of nanotechnology along with advanced delivery systems, including liposomes, phytosomes, and polymeric nanoparticles, has significantly improved the bioavailability and therapeutic performance of herbal drugs⁵.

In recent years, worldwide demand for herbal medicines has risen as awareness of natural and holistic therapeutic approaches has grown. As a result, the pharmaceutical industry and research institutions are increasingly focusing on developing herbal formulations that meet modern regulatory and quality standards. Herbal drug technology, therefore, acts as a bridge between traditional wisdom and contemporary pharmaceutical innovation, providing a scientific foundation for advancing the development of herbal medicines that are safe, efficacious, and globally recognized⁶.

1. Herbal Drug Technology:

Herbal drug technology is an evolving field of pharmaceutical science that combines traditional herbal knowledge with modern scientific and technological principles to develop standardized, safe, and efficacious herbal formulations. For thousands of years, plants have historically served as a key source of medicinal remedies in traditional practices like Ayurveda, Unani, Siddha, and Traditional Chinese Medicine. However combining these traditional treatments into modern healthcare requires scientific validation, quality assurance, and regulatory standardization⁷. Herbal drug technology provides the framework for achieving these goals by applying advanced analytical, biotechnological, and pharmaceutical approaches to herbal medicine development⁸.

The primary aim of herbal drug technology is to achieve uniformity and reproducibility in herbal formulations by standardizing raw materials, optimizing extraction processes, and developing novel delivery systems⁹. The identification and authentication of medicinal plants through macroscopic, microscopic, and molecular techniques such as DNA barcoding have significantly reduced the risk of adulteration and misidentification¹⁰. Chromatography is a highly effective analytical technique used to separate and quantitatively analyze numerous compounds, even within complex matrices¹¹. Extraction technology has also advanced considerably, the introduction of advanced methods—including supercritical fluid extraction, microwave-assisted extraction, and ultrasound-assisted extraction—has improved the yield, purity, and stability of bioactive constituents¹². Moreover, the use of nanotechnology and advanced drug delivery systems, including phytosomes, liposomes, nanoparticles, and nanoemulsions, has enhanced the solubility, stability, and bioavailability of phytoconstituents with poor water solubility¹³. For instance, curcumin-loaded nanoparticles and silymarin phytosomes have demonstrated superior pharmacokinetic and therapeutic profiles compared to conventional extracts⁷. In addition to formulation and delivery, the development of herbal drugs now involves biotechnological interventions such as plant tissue culture and metabolic engineering to ensure sustainable production of valuable phytochemicals¹⁴. Computational tools like molecular docking and network pharmacology are increasingly being employed to gain insight into the molecular-level mechanisms and interactions of herbal bioactive constituents¹⁵. These advances facilitate rational drug design to establish a scientific basis for traditional medicinal claims.

The renewed global interest in herbal medicines has also prompted the need for stringent quality control and regulatory guidelines. The World Health Organization (WHO) and various national pharmacopeias have issued monographs and standards for herbal drugs to promote safety, efficacy, and reproducibility¹⁶. Despite these advancements, challenges remain in achieving batch-to-batch consistency, addressing pharmacokinetic variability, and conducting large-scale clinical trials.

In conclusion, herbal drug technology serves as a critical link between ancient herbal wisdom and contemporary pharmaceutical innovation. Through advanced extraction, analytical standardization, nanotechnology, and biotechnology, this approach strengthens the therapeutic efficacy of herbal medicines and ensures adherence to international quality standards. Combining traditional medicinal knowledge with modern science validates the therapeutic effectiveness of herbal drugs and facilitates the identification of novel phytopharmaceuticals for future pharmaceutical research¹⁷.

2. Standardization of Herbal Drugs:

Standardization refers to a systematic approach that ensures uniform levels of quantity, quality, and therapeutic activity of ingredients per dose¹⁸. It involves a series of physicochemical, phytochemical, biological, and analytical evaluations designed to confirm the authenticity and uniformity of the product.

The first step in the standardization process is the authentication of raw materials, which includes botanical identification through macroscopic, microscopic, and organoleptic characteristics. The use of molecular tools such as DNA barcoding and polymerase chain reaction (PCR) has greatly improved the accuracy of plant identification, preventing adulteration and substitution in herbal formulations. Authentication ensures that only the appropriate species and plant parts are utilized, since variations in plant sources or collection method can significantly alter the chemical profile and pharmacological activity¹⁹.

Following authentication, Physicochemical evaluation is performed to determine parameters including moisture content, ash values, extractive values, pH, and volatile oil content. The assessed parameters provide insight into the purity and stability of the herbal material. Furthermore, phytochemical analysis is performed to detect the presence of bioactive constituents, including alkaloids, flavonoids, tannins, terpenoids, glycosides, and saponins²⁰. Modern chromatographic techniques include Thin Layer Chromatography (TLC), High-Performance Thin Layer Chromatography (HPTLC), High-Performance Liquid Chromatography (HPLC), and Gas Chromatography–Mass Spectrometry (GC–MS) are used to establish chemical fingerprints, which act as distinctive profiles for quality assurance and consistency between batches.

Furthermore, to chemical standardization, biological standardization is crucial for evaluating the therapeutic potential of herbal preparations. It involves conducting both in vitro and in vivo bioassays to confirm the medicinal effectiveness of the herbal drug. Such as, antioxidant, anti-inflammatory, and antimicrobial assays are commonly performed to assess biological potency. Furthermore, toxicological evaluation ensures that herbal formulations are free from heavy metals, pesticides, microbial contaminants, and mycotoxins²¹.

Recent advances in analytical technology have made metabolomic profiling and chemometric analysis valuable tools in herbal standardization. These approaches provide a holistic view of the chemical composition and enable correlation between phytochemical patterns and pharmacological effects⁹. The combined implementation of Good Agricultural and Collection Practices, Good Manufacturing Practices, and Good Laboratory Practices further strengthens the reliability of standardized herbal products²².

Despite significant progress, challenges remain in achieving global harmonization of standards for herbal medicines due to variations in regulatory frameworks, raw material sources, and traditional practices. Nevertheless, the development of standardized herbal drugs enhances consumer confidence and promotes the assimilation of traditional medical practices within modern healthcare frameworks.

In conclusion, standardization is the cornerstone of herbal drug technology, ensuring that herbal formulations are consistent, effective, and safe for therapeutic use. The combination of classical pharmacognostic methods with advanced analytical and molecular techniques has transformed herbal drug evaluation into a scientifically rigorous process, paving the way for global acceptance of herbal therapeutics²³.

3. Nanotechnology in Herbal Drug Delivery:

Nanotechnology has become a transformative tool in contemporary pharmaceutics, providing innovative approaches to improve the delivery, bioavailability, and therapeutic effectiveness of herbal medicines. Many phytoconstituents, though pharmacologically active, face challenges including low solubility, inadequate stability, and limited permeability, and rapid metabolism, leading to reduced bioavailability and inconsistent therapeutic outcomes²⁴. The application of nanotechnology in the delivery of herbal drugs provides solutions to these challenges by formulating herbal actives into nanosized carriers that improve their pharmacokinetic and pharmacodynamic properties.

Nanotechnology offers solutions to overcome the limitations of conventional methods used to enhance solubility and bioavailability²⁵. The primary objectives in nanoparticle-based drug delivery design include regulating particle size, surface characteristics, and drug release to achieve site-specific action at an optimal therapeutic rate and dosage²⁶. When applied to herbal remedies, nanocarriers can deliver an optimal amount of drug to the target site by overcoming physiological barriers such as gastric acidity and hepatic metabolism, while also prolonging systemic circulation due to their small size. The particle diameter of a nanoscale system is approximately 0.1µm, placing it within the submicrometer range²⁷. The United States, Europe, Japan, and other countries have established and supported initiatives to evaluate the potential hazards of nanomaterials under realistic exposure conditions, with the aim of encouraging the safe commercial application of nanotechnology²⁸.

Nanotechnology refers to the design and development of materials at the nanometer scale, typically ranging from 1 to 100nm to manipulate drug release, absorption, and targeting. Herbal formulations frequently employ nanocarrier systems such as liposomes, phytosomes, SLNs, NLCs, polymeric nanoparticles, nanoemulsions, and metallic nanoparticles. Such nanosystems enhance solubility and stability, safeguard poorly water-soluble herbal compounds against degradation, and facilitate controlled, targeted delivery²⁹.

Among various nanocarrier systems, phytosomes have emerged as one of the most effective approaches for herbal drug delivery. They are complexes of phospholipids and phytoconstituents that improve the lipophilicity and absorption of bioactives through biological membranes. For instance, curcumin, silymarin, and quercetin phytosomes have shown enhanced oral bioavailability and superior therapeutic activity compared to conventional extracts. Similarly, liposomes, composed of phospholipid bilayers, provide a biocompatible and biodegradable system for encapsulating hydrophilic and lipophilic phytoconstituents, protecting them from enzymatic degradation and improving systemic circulation time³⁰.

Fig 3.1 Size Scale of Biological and Nanostructures

An alternative approach to lipid-based delivery systems is offered by solid lipid nanoparticles (SLNs) and nanostructured lipid carriers (NLCs) for herbal drugs with high entrapment efficiency and controlled drug release profiles. These carriers have been effectively employed to deliver herbal compounds such as resveratrol, andrographolide, and fisetin, demonstrating enhanced brain targeting and antioxidant potential³¹. Polymeric nanoparticles, prepared from biodegradable polymers like PLGA, chitosan, or alginate, provide sustained release and targeted delivery, making them suitable for chronic conditions such as neurodegenerative and inflammatory diseases³².

In recent years, metallic nanoparticles, particularly those synthesized using plant extracts (green synthesis), have attracted considerable interest because of their simple design, environmentally friendly nature, and potential synergistic benefits Gold, silver, and zinc oxide nanoparticles derived from herbal extracts exhibit antimicrobial, antioxidant, and anticancer activities while reducing the need for toxic chemical reagents in synthesis¹².

The use of nanotechnology in herbal formulations also opens possibilities for targeted drug delivery. Functionalization of nanoparticles with specific ligands or antibodies allows site-specific delivery to target tissues, thereby reducing off-target effects and enhancing therapeutic efficacy¹³. Furthermore, the inclusion of nanotechnology with biotechnological and computational tools facilitates predictive modeling, toxicity assessment, and rational design of nano-herbal formulations¹⁴.

Nevertheless, issues related to scalability, regulatory clearance, toxicity assessment, and long-term safety must still be resolved to enable broad clinical application¹⁵. Standardized guidelines for characterization, stability testing, and rigorous quality control measures are critical to guarantee the reproducibility and safety of nanoformulated herbal products³³.

In conclusion, nanotechnology represents a paradigm shift in herbal drug technology, bridging the gap between traditional phytotherapy and advanced pharmaceutical science. By improving solubility, stability, bioavailability, and targeted delivery, nanocarrier-based systems significantly enhance the therapeutic promise of herbal medicines, thereby facilitating their global acceptance and commercialization¹⁶.

4. Phytosomes in Herbal Drug Delivery

Phytosomes are cell-like structures primarily used in the herbal industry to enhance effectiveness and address the limitations of herbal extracts³⁴. The term phytosome is derived from “phyto” (plant) and “some” (cell-like structure), describing a complex formed between plant-derived bioactive molecules and phospholipids, usually phosphatidylcholine¹. This unique formulation strategy overcomes many of the limitations associated with conventional herbal extracts by improving solubility, permeability, and stability of polar phytoconstituents².

Unlike simple mixtures or emulsions, phytosomes are true molecular complexes through hydrogen bond interactions between the polar head groups of phospholipids and the active phytoconstituent³. This interaction results in a lipid-compatible complex that easily integrates with biological membranes, enhancing the absorption of phytochemicals through the gastrointestinal tract. Phytosomes differ from liposomes in that the phytoconstituent is an integral part of the complex rather than being encapsulated within an aqueous core, thus improving both stability and bioavailability⁵.

Phytosomes are formed through the interaction of phospholipids with the phytoconstituents present in plant extracts³⁵. The most commonly employed phospholipid is phosphatidylcholine, a biocompatible compound with amphiphilic properties that facilitates membrane transport and protection of bioactives from enzymatic degradation. Characterization of phytosomes involves particle size analysis, zeta potential measurement, Differential scanning calorimetry (DSC), Fourier-transform infrared spectroscopy (FTIR), and scanning electron microscopy (SEM) are employed to verify complex formation and evaluate stability³⁶.

Phytosomes have been extensively studied for several herbal compounds, including silymarin, curcumin, ginkgo biloba, green tea polyphenols, and quercetin. Silymarin phytosome (marketed as Siliphos®) was among the first commercial formulations demonstrating markedly improved oral bioavailability and hepatoprotective efficacy compared to standard silymarin extract¹⁰. Similarly, curcumin phytosomes (e.g., Meriva®) exhibit enhanced systemic absorption, leading to superior anti-inflammatory and antioxidant effects¹¹. Ginkgo biloba phytosome has also been reported to improve memory and cognitive function due to increased brain bioavailability of flavone glycosides and terpene lactones³⁶.

Phytosome technology offers multiple pharmacokinetic advantages such as increased membrane permeability, prolonged circulation time, and targeted delivery to tissues. It also provides protection against environmental and gastrointestinal degradation, ensuring a more predictable therapeutic response. Moreover, due to their natural composition, phytosomes demonstrate high biocompatibility and low toxicity, rendering them appropriate for long-term therapeutic applications³⁷.

Recent advancements in nano-phytosome technology have further miniaturized particle size to the nanoscale, combining the benefits of nanocarriers and phospholipid complexes. These nano-phytosomes demonstrate even greater bioavailability, stability, and controlled release characteristics. Additionally, computational modeling and molecular docking studies have been employed to optimize phytoconstituent–phospholipid interactions and predict in vivo behaviour¹⁹.

In conclusion, phytosomes represent a bridge between traditional herbal therapy and modern drug delivery science. By transforming hydrophilic phytoconstituents into lipid-compatible complexes, they significantly improve absorption, stability, and pharmacological efficacy. Their proven clinical performance and safety profile make phytosomes one of the most promising technologies for the future development of standardized, effective, and patient-friendly herbal formulations.¹⁸

5. Bioavailability Enhancement of Herbal Drugs:

Bioavailability describes how quickly and to what extent an active drug substance is absorbed from a formulation and becomes available at its intended site of action. In herbal medicine, bioavailability is a key factor in determining the therapeutic effectiveness of phytoconstituents. However, many herbal compounds demonstrate limited oral bioavailability because of factors such as low water solubility, poor membrane permeability, gastrointestinal instability, rapid metabolism, and extensive first-pass metabolism. These limitations often lead to reduced plasma concentrations and inconsistent pharmacological responses. Therefore, improving the bioavailability of herbal drugs has become a major focus in herbal drug technology and formulation research³⁸.

Phytochemicals such as curcumin, silymarin, quercetin, berberine, and resveratrol are known for their potent pharmacological properties but have limited clinical effectiveness because of poor systemic absorption ³. Strategies for enhancing bioavailability involve both pharmaceutical and technological interventions, including formulation modification, absorption enhancement, and metabolism inhibition⁴.

One of the most successful approaches is the development of phytosome technology, where bioactive compounds form complexes with phospholipids, improving lipophilicity and membrane permeability⁵. For instance, silymarin phytosomes and curcumin phytosomes have demonstrated up to five- to ten-fold higher absorption compared to conventional extracts⁶.

Nanoformulation-based delivery systems, including nanoparticles, nanoemulsions, nanostructured lipid carriers (NLCs), and solid lipid nanoparticles (SLNs), have demonstrated significant potential in enhancing the solubility, stability, and controlled release of herbal compounds. Nanoencapsulation enhances surface area and dissolution rate, leading to improved gastrointestinal absorption. For example, fisetin-loaded PLGA nanosuspension demonstrated enhanced brain penetration and neuroprotective activity compared to free fisetin in experimental models of Alzheimer’s disease³⁹.

Another important strategy is the use of bioenhancers-natural or synthetic compounds that promote absorption and inhibit metabolic degradation. Piperine, derived from Piper nigrum, is a well-known bioenhancer that increases the bioavailability of curcumin, resveratrol, and other phytochemicals by inhibiting hepatic and intestinal glucuronidation⁴⁰. Similarly, quercetin and naringin act as permeability enhancers and P-glycoprotein inhibitors, further promoting drug absorption.

Solid dispersions and self-emulsifying drug delivery systems (SEDDS) have likewise been utilized to enhance the solubility and dissolution rate of poorly water-soluble herbal actives. These systems form fine emulsions in gastrointestinal fluids, enabling better absorption and minimizing variability caused by physiological factors. Cyclodextrin inclusion complexes enhance aqueous solubility of hydrophobic phytoconstituents like catechins and curcumin, resulting in improved dissolution and bioavailability⁴¹.

Recent research trends focus on combining nanotechnology with biopolymers and lipid-based carriers, leading to the development of hybrid systems capable of delivering herbal bioactives in a targeted, sustained, and controlled manner. Moreover, computational modeling and pharmacokinetic simulations have become valuable tools for predicting absorption mechanisms and optimizing formulation parameters¹⁶.

Despite these advances, challenges remain in translating improved in vitro absorption into consistent in vivo outcomes. Factors such as variability in plant material, physiological conditions, and metabolism may still influence systemic availability. Standardization of bioavailability studies and establishment of reliable biomarkers are essential for validating the clinical efficacy of enhanced herbal formulations⁴².

In conclusion, enhancing the bioavailability of herbal drugs is crucial for achieving their full therapeutic potential. Through innovative formulation strategies such as phytosomes, liposomes, nanoparticles, and bioenhancer incorporation, herbal drug technology has made significant progress in overcoming pharmacokinetic limitations. These advancements facilitate the development of more effective, predictable, and scientifically validated herbal therapeutics¹⁸.

6. Herbal Drug Quality Control:

Quality control systems rely on testing, inspection, auditing, and analysis to ensure standards are met. Consistency is essential, as variation undermines effective quality control.⁴³

Ensuring the quality of herbal drugs starts with accurate identification and authentication of raw materials, which ensures that the correct plant species and plant parts are used. This involves macroscopic and microscopic examination, along with organoleptic evaluations of color, odor, and texture. In addition, DNA fingerprinting and molecular marker techniques have emerged as reliable tools for identifying plant species and detecting adulteration or substitution⁴⁴.

Once authenticity is confirmed, Physicochemical parameters, including moisture content, ash values, extractive values, volatile oil content, pH, and swelling index, are evaluated. Such parameters are useful for assessing the purity and stability of herbal materials. Phytochemical evaluation is another key aspect, involving preliminary screening of active constituents like alkaloids, flavonoids, saponins, tannins, glycosides, and terpenoids. Advanced chromatographic and spectroscopic methods, including High Performance Thin Layer Chromatography (HPTLC), High Performance Liquid Chromatography (HPLC), Gas Chromatography–Mass Spectrometry (GC–MS), and Fourier Transform Infrared Spectroscopy (FTIR), are employed for fingerprint profiling and quantification of bioactive compounds⁴⁵.

Quality control of finished herbal products involves evaluating uniformity, stability, and freedom from contaminants. Common contaminants such as heavy metals (lead, mercury, arsenic, cadmium), pesticides, microbial load, and aflatoxins must be strictly monitored to ensure safety. Guidelines issued by the World Health Organization (WHO) and several pharmacopoeias, including the Indian Herbal Pharmacopoeia and British Herbal Pharmacopoeia, provide guidelines and acceptable limits for these contaminants⁴⁶.

Furthermore, Biological Evaluation plays a crucial role in validating the pharmacological potency of herbal formulations. In vitro and in vivo bioassays are employed to determine biological activity, while toxicological studies ensure safety before clinical use. Stability testing under varying temperature and humidity conditions helps establish shelf life and storage requirements for herbal products⁴⁶.

The adoption of Good Agricultural and Collection Practices (GACP), Good Manufacturing Practices (GMP), and Good Laboratory Practices (GLP) ensures the consistent production and quality control of herbal drugs in accordance with established standards¹⁰. These practices minimize variability due to environmental, seasonal, and processing factors. Additionally, the adoption of advanced approaches like chemometric analysis and metabolomics helps in comprehensive evaluation of chemical composition, thereby improving quality assurance.⁴⁷

In conclusion, quality control is a cornerstone of herbal drug technology, to guarantee that herbal medicines remain safe, efficacious, and dependable. The incorporation of traditional evaluation methods with modern analytical and biotechnological tools has revolutionized herbal drug standardization. Implementing stringent quality control measures not only protects consumer health but also strengthens the global credibility and acceptance of herbal medicines within modern healthcare systems⁴⁷.

CONCLUSION:

Overall, herbal drug technology acts as a vital bridge between traditional medicinal knowledge and modern pharmaceutical science. By integrating advanced extraction methods, rigorous analytical standardization, innovative nanotechnology-based delivery systems, and robust quality control measures, it transforms traditional herbal remedies into safe, effective, and scientifically validated therapeutics. Technologies such as phytosomes, nanoparticles, and bioenhancer-based formulations significantly improve the solubility, stability, absorption, and bioavailability of phytoconstituents, thereby maximizing their therapeutic potential. At the same time, standardization and stringent quality control ensure consistency, purity, and global compliance of herbal products. Collectively, these advancements elevate herbal medicine to modern pharmaceutical standards, enhance global credibility, and pave the way to support the identification and development of novel phytopharmaceutical agents for future healthcare.

REFERENCE:

1. World Health Organization. WHO Guidelines on Good Manufacturing Practices (GMP) for Herbal Medicines. Geneva: WHO; 2020.

2. Kokate CK, Purohit AP, Gokhale SB. Pharmacognosy. 54th ed. Pune: Nirali Prakashan; 2022.

3. Techen N, Parveen I, Pan Z, Khan IA. DNA barcoding of medicinal plant material for identification. Curr Opin Biotechnol. 2014; 25:103–110.

4. Mukherjee PK. Quality Control of Herbal Drugs: An Approach to Evaluation of Botanicals. 2nd ed. New Delhi: Business Horizons; 2019.

5. Chemat F, Vian MA, Cravotto G. Green extraction of natural products: concepts and principles. Int J Mol Sci. 2012;13(7):8615–8627.

6. Pandey S, Dahiya R. Nanotechnology-based approaches for enhancing the bioavailability of herbal drugs. J Drug Deliv Sci Technol. 2021; 64:102600.

7. Shinde UA et al. Phytosome formulations: a novel drug delivery system for herbal extracts. Pharmacogn Rev. 2020;14(28):97–106.

8. Rao SR, Ravishankar GA. Plant cell cultures: chemical factories of secondary metabolites. Biotechnol Adv. 2002; 20(2):101–153.

9. Fang J, Liu C, Wang Q, Lin P. Network pharmacology: a new approach to the study of herbal medicines. Front Pharmacol. 2021; 12:676736.

10. European Medicines Agency. Guidelines on Quality of Herbal Medicinal Products/Traditional Herbal Medicinal Products. EMA; 2019.

11. Jain T, Vyas A, Dubey D, Dashora K, Jain V. Development of HPLC fingerprinting method via estimation of piperine for Unani formulation Hab-e-Azarakhi. Asian J Pharm Anal. 2022;12(4):258-260

12. World Health Organization. Quality Control Methods for Herbal Materials. Geneva: WHO; 2011.

13. Kokate CK, Purohit AP, Gokhale SB. Pharmacognosy. 54th ed. Pune: Nirali Prakashan; 2022.

14. Techen N, Parveen I, Pan Z, Khan IA. DNA barcoding of medicinal plant material for identification. Curr Opin Biotechnol. 2014; 25:103–110.

15. Mukherjee PK. Quality Control of Herbal Drugs: An Approach to Evaluation of Botanicals. 2nd ed. New Delhi: Business Horizons; 2019.

16. Harborne JB. Phytochemical Methods: A Guide to Modern Techniques of Plant Analysis. 3rd ed. London: Chapman and Hall; 1998.

17. Reich E, Schibli A. High-Performance Thin-Layer Chromatography for the Analysis of Medicinal Plants. New York: Thieme; 2007.

18. Vakhariya RR, Talokar S, Dhole AR, Mohite SK, Magdum CS. Comparative standardization study of two marketed Shatavari churna formulations. Asian J Pharm Anal. 2016;6(1):1–6.

19. European Medicines Agency. Guidelines on Quality of Herbal Medicinal Products/Traditional Herbal Medicinal Products. EMA; 2019.

20. Xie PS, Leung AY. Understanding the traditional aspect of Chinese medicine in the context of chemical and biological network analyses. J Ethnopharmacol. 2009;122(2):297–301. WHO. Good Agricultural and Collection Practices for Medicinal Plants. Geneva: WHO; 2003.

21. Ekor M. The growing use of herbal medicines: issues relating to adverse reactions and challenges in monitoring safety. Front Pharmacol. 2014; 4:177.

22. Mukherjee PK. Quality Control of Herbal Drugs: An Approach to Evaluation of Botanicals. 2nd ed. New Delhi: Business Horizons; 2019.

23. Pandey S, Dahiya R. Nanotechnology-based approaches for enhancing the bioavailability of herbal drugs. J Drug Deliv Sci Technol. 2021; 64:102600.

24. 24.Patra JK, Das G, Fraceto LF, Campos EVR, Rodriguez-Torres MDP, et al. Nano based drug delivery systems: recent developments and future prospects. J Nanobiotechnol. 2018;16(1):71.

25. Kulkarni RR, Phadtare DG, Saudagar RB. A novel approach towards nanosuspension. Asian J Pharm Res. 2015;5(4):186–194.

26. Saudagar RB, Mandlik KT. A review on gold nanoparticles. Asian J Pharm Res. 2016;6(1):45–48.

27. Indalkar YR, Pimpodkar NV, Godase AS, Gaikwad PS. A comprehensive review on the study of nanotechnology for herbal drugs. Asian J Pharm Res. 2015;5(4):203–207.

28. Khan MY, Gupta P, Bihari B, Sharma VK, Aziz I. A review—miracle of nanotechnology in cosmetics. Asian J Pharm Res. 2014;4(1):16–23.

29. Rai M, Shegokar R. Nanotechnology in Herbal Medicine: Modern Applications and Challenges. Cham: Springer; 2020.

30. Kidd PM, Head K. A review of the bioavailability and clinical efficacy of silybin phytosome. Altern Med Rev. 2005;10(3):193–203.

31. Gregoriadis G. Liposome technology in drug and vaccine delivery: a brief overview. Mol Biotechnol. 2006;34(2):149–172.

32. Mehnert W, Mäder K. Solid lipid nanoparticles: production, characterization and applications. Adv Drug Deliv Rev. 2012; 64:83–101.

33. Thite D, et al. Fisetin-loaded PLGA nanosuspension: formulation and evaluation of neuroprotective potential in Alzheimer’s disease model. Neurochem Int. 2024; 185:106585.

34. Kattyar SL, Patil PS, Patil SV, Kadam SS. Phytosomes and recent research on phytosomal drugs. Asian J Pharm Anal. 2022;12(1):61–69.

35. Rayate Y, Shewale S, Patil A, Nitalikar M, Mohite S. Phytosomes—A novel approach in herbal drug delivery system. Asian J Res Pharm Sci. 2018;8(3):151–154.

36. Jain S, Patel N, Madan P. Advances in polymeric nanoparticle-based drug delivery for herbal therapeutics. Int J Pharm Sci Res. 2020;11(9):4505–4518.

37. Ahmed S, Saifullah, Ahmad M, Swami BL, Ikram S. Green synthesis of silver nanoparticles using Azadirachta indica aqueous leaf extract. J Radiat Res Appl Sci. 2016;9(1):1–7.

38. Roy A, Bulut O, Some S, Mandal AK, Yilmaz MD. Green synthesis of silver nanoparticles: biomolecule-nanoparticle organizations targeting antimicrobial activity. RSC Adv. 2019;9(5):2673–2702.

39. Li J, Mooney DJ. Designing hydrogels for controlled drug delivery. Nat Rev Mater. 2016;1(12):16071.

40. Singh N, Bhalla M, de Jager P, Gilca M. An overview on traditional medicine and its role in modern healthcare. Afr J Tradit Complement Altern Med. 2011;8(5 Suppl):28–36.

41. Ekor M. The growing use of herbal medicines: issues relating to adverse reactions and challenges in monitoring safety. Front Pharmacol. 2014; 4:177.

42. Singh N, Bhalla M, de Jager P, Gilca M. An overview on traditional medicine and its role in modern healthcare. Afr J Tradit Complement Altern Med. 2011;8(5 Suppl):28–36.

43. Sayankar VN, Kale MK. Study of reduction in time for use of computers in quality control system. Asian J Manage. 2011;2(3):94–97

44. Mukherjee PK. Quality Control of Herbal Drugs: An Approach to Evaluation of Botanicals. 2nd ed. New Delhi: Business Horizons; 2019.

45. Kidd PM, Head K. A review of the bioavailability and clinical efficacy of silybin phytosome. Altern Med Rev. 2005;10(3):193–203.

46. Maiti K, Mukherjee K, Gantait A, Saha BP, Mukherjee PK. Curcumin–phospholipid complex: preparation, therapeutic evaluation and pharmacokinetic study in rats. Int J Pharm. 2007;330(1-2):155–163.

47. Bhattacharya S. Phytosomes: the emerging technology for enhancement of bioavailability of botanicals and nutraceuticals. Int J Pharm Sci Tech. 2018;12(2):34–45.

Received on 18.12.2025 Revised on 20.01.2026

Accepted on 21.02.2026 Published on 21.04.2026

Available online from April 24, 2026

Res. J. Pharmacognosy and Phytochem. 2026; 18(2):156-162.

DOI: 10.52711/0975-4385.2026.00022

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License. Creative Commons License.